UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Journal of medical case reports, 2009-09, Vol.3 (1), p.9110-9110

2009

Volltextzugriff (PDF)

Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

Journal of immunotherapy (1997), 2007-09, Vol.30 (6), p.655-662

2007

Volltextzugriff (PDF)

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Journal of medical case reports, 2009-09, Vol.3 (1), p.9110-9110

2009

Volltextzugriff (PDF)

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score

Circulation (New York, N.Y.), 2019-11, Vol.140 (20), p.1639-1646

2019

Volltextzugriff (PDF)

Identification of a DRB3011:01-restricted CD4 + T cell response against bovine respiratory syncytial virus fusion protein

Frontiers in immunology, 2023-02, Vol.14, p.1040075-1040075

2023

Volltextzugriff (PDF)

Assessing Heterogeneity of Treatment Effect in Real-World Data

Annals of internal medicine, 2023-04, Vol.176 (4), p.536-544

2023

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models

Molecular cancer therapeutics, 2016-07, Vol.15 (7), p.1568-1579

2016

Volltextzugriff (PDF)

Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation

Journal of the American Heart Association, 2020-12, Vol.9 (24), p.e018378

2020

Volltextzugriff (PDF)

Abstract 12993: Oral Anticoagulation Prescription Depends on Both Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3)

2020

Volltextzugriff (PDF)

Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types

Cancer biology & therapy, 2010-04, Vol.9 (8), p.618-631

2010

Volltextzugriff (PDF)

Sex Differences in Pain-Related Central Nervous System-Mediated Symptom Clusters in Children with Multisite Pain

The journal of pain, 2024-04, Vol.25 (4), p.67-67

2024

Volltextzugriff (PDF)

Expanding Interprofessional Teams: Training Future Health Care Professionals in Screening, Brief Intervention, and Referral to Treatment (SBIRT)

Families systems & health, 2022-12, Vol.40 (4), p.559-565

2022

Volltextzugriff (PDF)

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

Circulation (New York, N.Y.), 2019-11, Vol.140 (20), p.1639-1646

2019

Volltextzugriff (PDF)

Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?

Journal of the American Podiatric Medical Association, 2008-11, Vol.98 (6), p.489-493

2008

Volltextzugriff (PDF)

c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations

The Journal of biological chemistry, 2008-02, Vol.283 (5), p.2675-2683

2008

Volltextzugriff (PDF)

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase

Journal of medicinal chemistry, 2008-05, Vol.51 (10), p.2879-2882

2008

Volltextzugriff (PDF)

Atrial fibrillation variability on long‐term monitoring of implantable cardiac rhythm management devices

Clinical cardiology (Mahwah, N.J.), 2017-11, Vol.40 (11), p.1044-1048

2017

Volltextzugriff (PDF)

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype

Nature communications, 2015-03, Vol.6 (1), p.6548-6548, Article 6548

2015

Volltextzugriff (PDF)

Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)

Journal of medicinal chemistry, 2008-07, Vol.51 (13), p.3688-3691

2008

Volltextzugriff (PDF)

Safety and Pain Palliation of Zoledronic Acid in Patients with Breast Cancer, Prostate Cancer, or Multiple Myeloma Who Previously Received Bisphosphonate Therapy

The oncologist (Dayton, Ohio), 2004-11, Vol.9 (6), p.687-695

2004

Volltextzugriff (PDF)

Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (16), p.6680-6687

2008

Volltextzugriff (PDF)

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

NPJ breast cancer, 2018-08, Vol.4 (1), p.26-5, Article 26

2018

Volltextzugriff (PDF)

Abstract 5089: Combined treatment of trebananib (AMG 386) with panitumumab in preclinical tumor models

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5089-5089

2013

Volltextzugriff (PDF)

Abstract 728: AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.728-728

2014

Volltextzugriff (PDF)

Abstract 12993: Oral Anticoagulation Prescription Depends on Both Atrial Fibrillation Duration and CHA2DS2-VASc Score

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A12993-A12993

2020

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(14)
Animals
(10)
Female
(10)
Mice
(9)
Biological And Medical Sciences
(6)
Oncology
(6)
Cell Line, Tumor
(5)
Male
(5)
Medical Sciences
(5)
Proto-Oncogene Proteins C-Met - Antagonists & Inhibitors
(5)
Aged
(4)
Proto-Oncogene Proteins C-Met - Metabolism
(4)
Xenograft Model Antitumor Assays
(4)
Antineoplastic Agents
(3)
Atrial Fibrillation
(3)
Cardiac & Cardiovascular Systems
(3)
Cardiovascular System & Cardiology
(3)
Cell Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score

Identification of a DRB3011:01-restricted CD4 + T cell response against bovine respiratory syncytial virus fusion protein

Assessing Heterogeneity of Treatment Effect in Real-World Data

In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models

Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation

Abstract 12993: Oral Anticoagulation Prescription Depends on Both Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types

Sex Differences in Pain-Related Central Nervous System-Mediated Symptom Clusters in Children with Multisite Pain

Expanding Interprofessional Teams: Training Future Health Care Professionals in Screening, Brief Intervention, and Referral to Treatment (SBIRT)

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?

c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase

Atrial fibrillation variability on long‐term monitoring of implantable cardiac rhythm management devices

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype

Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)

Safety and Pain Palliation of Zoledronic Acid in Patients with Breast Cancer, Prostate Cancer, or Multiple Myeloma Who Previously Received Bisphosphonate Therapy

Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

Abstract 5089: Combined treatment of trebananib (AMG 386) with panitumumab in preclinical tumor models

Abstract 728: AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models

Abstract 12993: Oral Anticoagulation Prescription Depends on Both Atrial Fibrillation Duration and CHA2DS2-VASc Score

Aktive Filter

Suchergebnisse filtern